Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
This report contains market size and forecasts of Digital Biomarker in Global, including the following market information:
Global Digital Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Digital Biomarker market was valued at 398.5 million in 2021 and is projected to reach US$ 23440 million by 2028, at a CAGR of 79.0% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Passive Digital Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Digital Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Digital Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Type, 2021 (%)
Passive Digital Biomarker
Active Digital Biomarker
Global Digital Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Application, 2021 (%)
Clinical Disease
Daily Health
Global Digital Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Digital Biomarker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digital Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Digital Biomarker revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics